Enter the Batch Number stamped on your packaging to view lab analysis and manufacturing details.
| Batch Number Uitramax T-261032 | Product Name | Mfg Date | Exp Date | Quality Status | Lab Report ( COA) |
|---|---|---|---|---|---|
| PARA001 | Paracetamol Tablets | 08/2026 | 07/2028 | Passed | Download COA |
| test 2 | aa | aa | aa | aa | test 2 |
| T-260918 | Livoros | 09/2026 | 08/2028 | Assay Passed 100.02 % | Livoros |
| T-260971 | Kidace Tablets | 09/2026 | 08/2028 | Assay Passed 99.19% | Kidace |
| S-261001 | Prim Suspension | 10/2026 | 09/2028 | Trimethoprim IP Assay Passed 100.10% Sulphamethoxazole IP Assay Passed 98.78% | Prim Suspension |
| T-261009 | Troupe | 10/2026 | 09/2028 | Paracetamol IP Assay Passed 101.21% Diclofenac Sodium IP Assay Passed 99.88% | Troupe Tablets |
| T-260919 | Famotidine Tablets IP 40 mg | 09/2026 | 08/2028 | famotidine IP Assay Passed 98.05% | famotidine Tablets IP 40 mg |
| S-261002 | Meenured Syrup | 10/2026 | 09/2028 | Ferric Ammonium citrate IP Eq.to Elemental Iron Assay Passed 100.12% Cyanocobalamin IP Assay Passed 107.33% Folic Acid IP assay Passed 118.73% | Meenured Syrup |
| T-261001 | Voglee GM 3/0.3 SR Forte Tablets | 10/2026 | 09/2028 | Metformin Hcl IP Assay Passed 99.40% Glimepiride IP Assay Passed 102.66% Voglibose IP Assay Passed 108.96% | Voglee GM 30.3 SR Forte |
| T-261021 | BIG COLD TOTAL ADVANCE | 10/2026 | 09/2028 | Paracetamol IP Assay Passed 101.43% Ambroxol Hydrochloride IP Assay Passed 97.66% Guaiphenesin IP Assay Passed 100.82% Phenylephrine Hydrochloride IP Assay Passed 99.60% Cetirizine Hydrochloride IP Assay Passed 98.20% | BIG COLD TOTAL ADVANCE |
| T-260972 | Domtab tablets | 09/2026 | 08/2028 | Domperidone Maleate IP Eq. to domperidone Assay Passed 99.64% | Domtab Tablets |
| T261043 | ONDE-LEAP-4 MD | 10/2026 | 09/2028 | Ondansetron HCl IP Eq.to Ondansetron Assay Passed 101.25% | Onde-Leap-4 MD |
| T-261022 | ULTRAEASE TABLETS | 10/2026 | 09/2028 | Tramadol Hcl IP Assay Passed 101.14% Acetaminophen IP Assay Passed 101.12% | ultaease tablets T-261022 |
| T-261004 | Cetirizine tablets | 10/2026 | 09/2028 | cetirizine Hydrochloride IP Assay Passed 99.90% | Cetirizine tablets T-261004 |
| T-260917 | Care Cold Tablets | 09/2026 | 08/2028 | Paracetamol IP Assay Passed 100.43% Phenylephrine HCl IP Assay Passed 98.20% Chlorpheniramine Maleate IP Assay Passed 104.50% | Care Cold Tablets |
| S-261003 | IBULIAZ-P Suspension | 10/2026 | 09/2028 | Paracetamol IP Assay Passed 99.58% Ibuprofen IP Assay Passed 98.11% | IbULIAZ -P Suspension |
| C-261001 | NERIWON 300 Capsules | 10/2026 | 09/2028 | Pregabalin IP Assay Passed 99.02% | Nerviwon 300 Capsules |
| C-261003 | NERVIWON 300 Capsules | 10/2026 | 09/2029 | Pregabalin IP Assay Passed 98.34% | Nerviwon 300 Capsules . |
| C-261002 | NERVIWON 300 Capsules | 10/2026 | 09/2029 | Pregabalin IP Assay Passed 99.50% | Nerviwon 300 Capsules .. |
| T-261016 | ALAR | 10/2026 | 09/2028 | Cetirizine Hydrochloride IP Assay Passed 100.70% | ALAR |
| T-260819 | Ascorbic Acid Tablets IP | 08/2026 | 07/2028 | Ascorbic Acid IP Assay Passed 99.98% | Ascorbic Acid Tablets IP |
| T-261027 | Clonaz P 0.5/20 Tablets | 10/2026 | 09/2028 | Clonazepam IP Assay Passed 101% Propranolol HCl IP Assay Passd 100.40% | Clonaz P 0.520 Tablets |
| T-261012 | MENDSPAS Tablets | 10/2026 | 09/2028 | Mefenamic Acid IP Assay Passed 100.58% Dicyclomine Hcl IP Assay Passd 100.10% | Mendspas Tablets T-261012 |
| T-261011 | MENDSPAS Tablets | 10/2026 | 09/2028 | Mefenamic Acid IP Assay Passed 99.69% Dicyclomine Hcl IP Assay Passd 100.10% | Mendspas Tablets T-261011 |
| T-261002 | Ofast-200 Tablets | 10/2026 | 09/2028 | Ofloxacin IP Assay Passed 100.98% | Ofast-200 Tablets |
| T-260927 | Metronidazole Tablets IP | 09/2026 | 08/2028 | Metronidazole Tablets IP Assay Passed 97.8% | Metronidazole Tablets IP |
| T-260920 | Carmont LC | 09/2026 | 08/2028 | Montelukast Sodium Eq.To Montelukast Assay passed 103% Levocetirizine Hcl IP Assay Passed 99.8% | Carmont LC T-260920 |
| T-260929 | ALAR | 09/2026 | 08/2028 | Cetirizine Hydrochloride IP Assay Passed 101.80% | ALAR T-260929 |
| T-261026 | Phenylbutazone Tablets IP 200Mg | 10/2026 | 09/2028 | Phenylbutazone IP Assay Passed 99.79% | Phenylbutazone Tablets IP 200 mg T-261026 |
| T-260848 | Phenylbutazone Tablets IP 100Mg | 08/2026 | 07/2028 | Phenylbutazone IP Assay Passed 99.16% | Phenylbutazone Tablets IP 100 mg T-260848 |
| S-261004 | Caremycetine Suspension | 10/2026 | 09/2028 | Chloramphenicol Palmitate IP Eq.to Chloramphenicol. Assay Passed 99.23% | Caremycetine Suspension S-261004 |
| T-261073 | Vitapic -C | 10/2026 | 09/2028 | Ascorbic Acid IP Assay Passed 100.78% Zinc Sulphate IP Eq. to zinc Assay Passd 100.4% | Vitapic-C T-261073 |
| T-261074 | Vitapic -C | 10/2026 | 09/2028 | Ascorbic Acid IP Assay Passed 100.18% Zinc Sulphate IP Eq. to zinc Assay Passd 100% | Vitapic -C T-261074 |
| T-261056 | Metamin -G1 SR Tablets | 10/2026 | 09/2028 | Metformin Hcl IP Assay Passed 99.53% Glimepiride IP Assay Passed 98.7% | Metamin -G1 SR Tablets T-261056 |
| T-261070 | Nebolife -AX Tablets | 10/2026 | 09/2028 | Montelukast Sodium Eq.To Montelukast Assay passed 98.2% Levocetirizine Hcl IP Assay Passed 101% Ambroxol Hydrochloride IP Assay Passed 99.70% | Nebolife -AX Tablets T-261070 |
| T-261032 | Ultramax | 10/2026 | 09/2028 | Tramadol Hcl IP Assay Passed 98.48% Acetaminophen IP Assay Passed 98.55% | Uitramax T-261032 |
| T-261045 | Clonaz MD Tablets | 10/2026 | 09/2028 | Clonazepam IP Assay Passed 101.12% | Clanaz MD Tablets T-261045 |
| T-261015 | Neuromex- Forte | 10/2026 | 09/2028 | Thiamine Mononitrate IP Assay Passed 119.7% Pyridoxine Hydrochloride IP Assay Passed Assay Passed 120.66% Cyanocobalamin IP Assay passed 106.93% Niacinamide IP Assay Passed 121.88% Calcium Pantothenate IP Assay Passed 117.8% | Neuromex-Forte T-261015 |
| T-261008 | Tada 4X Tablets | 10/2026 | 09/2028 | Dapoxetine HCl Assay Passed 97.63% Tadalafil IP Assay Passed 98.5% | Tada 4X Tablets T-261008 |
| T-261072 | Ibutab-Plus Tablets | 10/2026 | 09/2028 | Paracetamol IP Assay Passed 100.99% Ibuprofen IP Assay Passed 98.27% | Ibutab-Plus Tablets T-261072 |
| T261047 | Metros- 850 Tablets | 10/2026 | 03/2029 | Metformin HCl IP Assay Passed 99.44% | Metros-850 Tablets T-261047 |
| T-261055 | FOLIQUIK | 10/2026 | 09/2028 | Folic Acid IP Assay Passed 99.2% | Foliquik T-261055 |
| T-261075 | Amlofyn-5 | 10/2026 | 09/2028 | Amlodipine Besylate Assay Passed 102.2% | Amlofyn-5 T-261075 |
| T-261023 | Leozen Tablets | 10/2026 | 09/2028 | Levocetirizine Dihydrochloride IP Assay Passed 102% | Leozen Tablets T-261023 |
| T-261065 | AminoPhylline -100 | 10/2026 | 09/2028 | Aminophylline Assay Passed 101.3% | AminoPhylline -T-261065 |
| T-260969 | Diclofenac Potassium Tablet IP 50 mg | 09/2026 | 08/2028 | Diclofenac Potassium IP Assay Passed 99.98% | DIclofenac Potassium Tablets IP 50mg T-260969 |
| T-261054 | Folic Acid Tablets IP 5mg | 10/2026 | 09/2028 | Folic Acid IP Assay Passed 99.2% | Folic acid Tablets IP 5mg T-261054 |
| C-261004 | NERVIWON 300 Capsules | 10/2026 | 09/2029 | Pregabalin IP Assay Passed 99.77% | Nerviwon 300 Capsules C-261004 |
| C-261007 | NERVIWON 300 Capsules | 10/2026 | 09/2029 | Pregabalin IP Assay Passed 100.01% | Nerviwon 300 capsules C-261007 |
| C-261006 | NERVIWON 300 Capsules | 10/2026 | 09/2029 | Pregabalin IP Assay Passed 99.72% | Nerviwon 300 Capsules C-261006 |